GLO1 overexpression was already associated with protective effects against neuroglial and vascular lesions [48], and its mutations could be involved in cancer onset [49], as well as in several genetic pathologies like cerebral cavernous malformations (CCMs) [50] and retinitis pigmentosa [11]. The gene discussed is GLO1; the disease is cerebrocostomandibular syndrome.